Functional genomics and target gene validation in experimental and human disease

Johannes H Schulte1, Julika Pitsch2, Albert J Becker2

  • 1University Children's Hospital of Essen, Hufelandstr. 55, 45122 Essen, Germany.

Insights

Common complex diseases involve multiple gene expression changes. Integrating human data with animal models via data mining helps identify disease-causing genes and develop new treatments for these multifactorial disorders.

Area of Science:

  • Genetics and Molecular Biology
  • Disease Pathogenesis
  • Translational Medicine

Background:

  • Frequent multifactorial diseases, unlike rare monogenic disorders, involve complex genetic interactions and multiple gene expression alterations.
  • Understanding the genetic basis of common diseases like neuronal disorders and neoplasms is crucial for developing effective therapies.
  • Current approaches often focus on single genes, necessitating new strategies for complex, polygenic conditions.

Purpose of the Study:

  • To explore the integration of data mining with human disease tissue and animal model information.
  • To identify and validate key genes involved in the pathogenesis of multifactorial diseases.
  • To establish a framework for developing novel treatment pathways for common complex disorders.

Main Methods:

  • Utilizing data mining techniques to integrate information from human disease tissues.
  • Employing animal models for functional validation of candidate genes identified through data analysis.
  • Comparative analysis of gene expression patterns in disease states versus healthy controls.

Main Results:

  • Data mining successfully identified a multitude of genes with altered expression in multifactorial diseases.
  • Functional validation in animal models confirmed the pathogenetic significance of several key target genes.
  • The integrated approach enhanced the understanding of complex disease mechanisms.

Conclusions:

  • Integrating human disease data with animal model studies via data mining is a powerful strategy.
  • This approach increases the pathogenetic significance of identified target genes for common disorders.
  • Functional validation in animal models is essential for advancing new treatment development for complex diseases.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
119
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.6K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.8K
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
35.4K
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
248
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.4K